大麻二酚 (CBD) 消费者健康市场：按产品、分销管道和地区 - 规模、份额、前景、机会分析，2023-2030 年

Cannabidiol (CBD) Consumer Health Market, By Products, By Distribution Channel, By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年08月08日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计到 2030 年，全球大麻二酚 (CBD) 消费者保健市场价值将达到 820 亿美元，2023 年至 2030 年复合年增长率为 23.2%。

报告范围		报告详细资料
基准年	2022	2023 年市场规模	190亿美元
过去的资料	2018年至2021年	预测期间	2023-2030
预测 2023-2030 年复合年增长率：	23.20%	2030年价值预测	820亿美元

大麻二酚(CBD) 是一种常见于大麻和大麻植物中的化合物，这种萃取物已被证明可以治疗多种疾病，包括慢性疼痛、神经性疼痛、焦虑、睡眠障碍、噁心和压力。被发现是有效的。因此，大麻二酚在各地受到广泛欢迎。这种萃取物约占整株植物的 40%，已知对人体没有成瘾作用。 CBD 天然存在于大麻植物中。虽然这种油是从大麻中提取的，但它没有其他大麻产品的有害影响。 CBD油在治疗多种健康疾病方面也显示出积极的效果，包括阿兹海默症、多发性硬化症和帕金森氏症。

市场动态：

注入 CBD 的产品是全球的最新趋势。人们对 CBD 产品的医疗益处的认识不断提高，导致越来越多的人不考虑成本地购买这些产品，预计这将在预测期内推动全球大麻二酚 (CBD) 消费者健康市场的发展。生长。

目前，亚太地区有多家营养保健品公司提供各种形式的补充品和功能性食品。例如，澳洲公司MGC Pharma在中国推出了CBD营养补充品产品线，包括CBD胶囊、水溶性CBD溶液和大麻粉。这些产品在短时间内获得了消费者的广泛接受，因为它们提供了 CBD 的健康益处，但没有精神作用。此外，亚太地区各国大麻合法化增加了对大麻衍生 CBD 产品的需求。

本研究的主要特点

本报告详细分析了全球大麻二酚 (CBD) 消费者健康市场，包括以 2022 年为基准年的预测期（2023-2030 年）的市场规模和復合年增长率 (CAGR%)。）提供。
它也阐明了各个细分市场的潜在收入机会，并概述了该市场有吸引力的投资主张矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和批准、市场趋势、区域前景、主要参与者采取的竞争策略等的重要见解。
根据公司亮点、产品组合、主要亮点、财务表现和策略等参数，介绍全球大麻二酚 (CBD) 消费者健康市场的领先公司。
本研究涵盖的主要公司包括 CV Sciences, Inc.、Medical Marijuana, Inc.、AXIM-Biotechnologies, Inc.、Charlotte's Web、Endoca、Isodiol International Inc.、Elixinol、Folium Biosciences 和 NuLeaf Naturals, LLC 、 Cannoid 、 LLC 等。
该报告的见解将使行销人员和公司高层能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
《全球大麻二酚(CBD) 消费者健康市场报告》满足该行业的各种利益相关者的需求，例如投资者、供应商、产品製造商、分销商、新进入者和财务分析师。
利害关係人可以透过在分析全球大麻二酚 (CBD) 消费者健康市场时使用的各种策略矩阵来促进决策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 19.0 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	23.20%	2030 Value Projection:	US$ 82.0 Bn

Cannabidiol (CBD) is a compound commonly found in hemp and marijuana plants, this extract is found to be effective against numerous disorders such as chronic pain, neurological pain, anxiety, sleep disorder, as well as nausea and stress. Hence, cannabidiol is gaining widespread popularity across various regions. This extract consists approximately 40% of the entire plant and it is known to not cause any dependence effects on the human body. CBD is found naturally in marijuana plants. Though the oil is derived from marijuana, it does not have any harmful effects like any other product derived from cannabis. CBD oil is also showing positive results in treating various health disorders such as Alzheimer's disease, multiple sclerosis, Parkinson's disease, and others.

Market Dynamics:

CBD-infused products have become the latest trend across the world. Increasing awareness about the medical benefits of CBD-infused products is leading to an increase in the number of people willing to buy these products, irrespective of cost and this is expected to augment the growth of the global cannabidiol (CBD) consumer health market during the forecast period.

In the Asia Pacific region, several nutraceutical companies are now offering a wide variety of supplements and functional foods in various forms. For instance, an Australian company-MGC Pharma-launched its CBD nutraceutical-product line, including CBD capsules, water-soluble CBD solutions, and hemp powder, in China. These products have gained significant acceptance among consumers within a short span, as they offer health benefits of CBD without any psychoactive effects. In addition, the demand for hemp-derived CBD products is increasing due to the legalization of hemp in various countries in the Asia Pacific region.

Key features of the study:

This report provides in-depth analysis of the global cannabidiol (CBD) consumer health market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global cannabidiol (CBD) consumer health market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include CV Sciences, Inc., Medical Marijuana, Inc., AXIM-Biotechnologies, Inc., Charlotte's Web, Endoca, Isodiol International Inc., Elixinol, Folium Biosciences, NuLeaf Naturals, LLC, Cannoid, LLC, among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global cannabidiol (CBD) consumer health market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cannabidiol (CBD) consumer health market.

Detailed Segmentation:

Global Cannabidiol (CBD) Consumer Health Market, By Products:
- Medical OTC Products Targeted Therapy
- Analgesics
- Dermatology
- Mental Health
- Sleeping Aids
- Others
- Nutraceuticals
- CBD Vitamins and Dietary Supplements (VDS)
- CBD Sports Nutrition
- CBD Weight Management and Wellbeing
Global Cannabidiol (CBD) Consumer Health Market, By Distribution Channel:
- Online Stores
- Retail Pharmacies
- Retail Stores
Global Cannabidiol (CBD) Consumer Health Market, By Geography:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Company Profiles:
- CV Sciences, Inc.
- Medical Marijuana, Inc.
- AXIM-Biotechnologies, Inc.
- Charlotte's Web
- Endoca
- Isodiol
- Elixinol
- Folium Biosciences
- Cannoid, LLC

Market Dynamics
- Cannabis revolution positively impacting consumer health market
- Availability of alternatives to CBD supplements
- Uncertain government regulations related to CBD and CBD products
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Cannabidiol (CBD) Consumer Health Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Cannabidiol (CBD) Consumer Health Market, By Products, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Medical OTC Products
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Analgesics
Dermatology
Mental Health
Sleeping Aids
Others
Nutraceuticals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
CBD Vitamins and Dietary Supplements (VDS)
CBD Sports Nutrition
CBD Weight Management and Wellbeing

6. Global Cannabidiol (CBD) Consumer Health Market, By Distribution Channel, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Online Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)
Retail Stores
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Bn)

7. Global Cannabidiol (CBD) Consumer Health Market, By Region, 2023-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)
Middle East and Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products, 2023-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Bn)

8. Competitive Landscape

CV Sciences, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medical Marijuana, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AXIM-Biotechnologies, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Charlotte's Web
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Endoca
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Isodiol
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Elixinol
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Folium Biosciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
NuLeaf Naturals, LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cannoid, LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views